The MSK PGY2 Oncology Residency training builds on the foundations of pharmacy practice established during Doctor of Pharmacy (PharmD) education and the PGY1 pharmacy residency experience. The MSK PGY2 Oncology Residency provides residents with a 12 month learning experience that prepares them to function independently as a clinical pharmacy practitioner in oncology, to serve as a fully integrated member of a multi-disciplinary team, and to optimize medications used in the provision of cancer care. Residents who successfully complete a PGY2 Oncology Residency at MSK will possess competencies that prepare them for future clinical, research or academic positions, leadership roles in oncology, and board certification in oncology pharmacy. The adult oncology specialty residency provi